activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	995143	CHEMBL772572	Inhibition of Protein kinase C related kinase 1 (PRK1)	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	IC50	nM	1700.0	CHEMBL3384	Homo sapiens	IC50	uM	1.7
	995143	CHEMBL772572	Inhibition of Protein kinase C related kinase 1 (PRK1)	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	IC50	nM	1700.0	CHEMBL3384	Homo sapiens	IC50	uM	1.7
	2470313	CHEMBL992490	Inhibition of PKN1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL3384	Homo sapiens	INH	%	10.0
	2595785	CHEMBL1019782	Binding affinity to PKN1	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	200.0	CHEMBL3384	Homo sapiens	Kd	nM	200.0
	2596889	CHEMBL1017908	Inhibition of PKN1 assessed as enzyme activity relative to control	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Activity	%	0.7	CHEMBL3384	Homo sapiens	Activity	%	0.7
	2905150	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905151	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905152	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905153	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905154	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905155	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905156	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	180.0	CHEMBL3384	Homo sapiens	Kd	nM	180.0
	2905157	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905158	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905159	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	200.0	CHEMBL3384	Homo sapiens	Kd	nM	200.0
	2905160	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905161	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905162	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905163	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905164	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	3500.0	CHEMBL3384	Homo sapiens	Kd	nM	3500.0
	2905165	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905166	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905167	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905168	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905169	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905170	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905171	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	350.0	CHEMBL3384	Homo sapiens	Kd	nM	350.0
	2905172	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905173	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905174	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905175	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	9.3	CHEMBL3384	Homo sapiens	Kd	nM	9.3
	2905176	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905177	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905178	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905179	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905180	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905181	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905182	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1.3	CHEMBL3384	Homo sapiens	Kd	nM	1.3
	2905183	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	1900.0	CHEMBL3384	Homo sapiens	Kd	nM	1900.0
	2905184	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	710.0	CHEMBL3384	Homo sapiens	Kd	nM	710.0
	2905185	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1500.0	CHEMBL3384	Homo sapiens	Kd	nM	1500.0
	2905186	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2905187	CHEMBL1051253	Binding constant for PKN1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	2921204	CHEMBL1057599	Inhibition of PKN1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL3384	Homo sapiens	Activity	%	100.0
	3052457	CHEMBL1072495	Residual activity of PRK1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	94.0	CHEMBL3384	Homo sapiens	Residual activity	%	94.0
	3052709	CHEMBL1042972	Residual activity of PRK1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	99.0	CHEMBL3384	Homo sapiens	Residual activity	%	99.0
	3054018	CHEMBL1071348	Residual activity of PRK1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	91.0	CHEMBL3384	Homo sapiens	Residual activity	%	91.0
	3054270	CHEMBL1072495	Residual activity of PRK1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	99.0	CHEMBL3384	Homo sapiens	Residual activity	%	99.0
	3055557	CHEMBL1042972	Residual activity of PRK1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	98.0	CHEMBL3384	Homo sapiens	Residual activity	%	98.0
	3056862	CHEMBL1071348	Residual activity of PRK1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	83.0	CHEMBL3384	Homo sapiens	Residual activity	%	83.0
	3057114	CHEMBL1072495	Residual activity of PRK1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	96.0	CHEMBL3384	Homo sapiens	Residual activity	%	96.0
	3058434	CHEMBL1042972	Residual activity of PRK1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	97.0	CHEMBL3384	Homo sapiens	Residual activity	%	97.0
	3059718	CHEMBL1071348	Residual activity of PRK1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	68.0	CHEMBL3384	Homo sapiens	Residual activity	%	68.0
	3214026	CHEMBL1103221	Inhibition of PKN1 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	9.0	CHEMBL3384	Homo sapiens	INH	%	9.0
	3224921	CHEMBL1100999	Inhibition of PRK1 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL3384	Homo sapiens	INH	%	50.0
	3226300	CHEMBL1100999	Inhibition of PRK1 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL3384	Homo sapiens	INH	%	50.0
Not Active	3293120	CHEMBL1108243	Inhibition of PRK1 at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)Cc1ccccc1CC2=O		CHEMBL1096459		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	3293136	CHEMBL1108243	Inhibition of PRK1 at 10 uM	B	O=C1Cc2ccccc2Cc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL1096460		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	3293152	CHEMBL1108243	Inhibition of PRK1 at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)Cc1ccccc1CC2=O		CHEMBL1096466		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	3293168	CHEMBL1108243	Inhibition of PRK1 at 10 uM	B	O=C1Cc2ccccc2Cc2cc(Nc3ccccc3)ccc21		CHEMBL1096672		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	3293184	CHEMBL1108243	Inhibition of PRK1 at 10 uM	B	Nc1ccc(Nc2ccc3c(c2)Cc2ccccc2CC3=O)cc1		CHEMBL1096769		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	3293200	CHEMBL1108243	Inhibition of PRK1 at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)C(=O)Cc1ccccc1C2		CHEMBL1096770		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	3293216	CHEMBL1108243	Inhibition of PRK1 at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)Cc1ccccc1C(=O)C2		CHEMBL1096771		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	3293232	CHEMBL1108243	Inhibition of PRK1 at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)Cc1ccccc1C(=O)C2		CHEMBL1097085		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	3293248	CHEMBL1108243	Inhibition of PRK1 at 10 uM	B	O=C1Cc2ccc(Nc3ccccc3)cc2Cc2ccccc21		CHEMBL1097086		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	3293264	CHEMBL1108243	Inhibition of PRK1 at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)CC(=O)c1ccccc1C2		CHEMBL1097087		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	3293280	CHEMBL1108243	Inhibition of PRK1 at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)CC(=O)c1ccccc1C2		CHEMBL1097088		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	3293296	CHEMBL1108243	Inhibition of PRK1 at 10 uM	B	O=C1Cc2cc(Nc3ccccc3)ccc2Cc2ccccc21		CHEMBL1096988		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	3293312	CHEMBL1108243	Inhibition of PRK1 at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)Oc1ccccc1NC2=O		CHEMBL1098461		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	3293328	CHEMBL1108243	Inhibition of PRK1 at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)Oc1ccccc1NC2=O		CHEMBL1098462		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	3293344	CHEMBL1108243	Inhibition of PRK1 at 10 uM	B	O=C1Cc2ccccc2Cc2cc(-c3ccccc3)ccc21		CHEMBL1096442		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	3293360	CHEMBL1108243	Inhibition of PRK1 at 10 uM	B	O=C1Cc2ccccc2Cc2cc(NCc3ccccc3)ccc21		CHEMBL1097171		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
	3308639	CHEMBL1117734	Inhibition of PKN1 at 10 uM	B	Cc1c(-c2ccnc(N)n2)sc2ccc(Cc3cccc(O)c3)cc12		CHEMBL1082758	=	Inhibition	%	53.0	CHEMBL3384	Homo sapiens	INH	%	53.0
	3332104	CHEMBL1166815	Inhibition of PKN1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3384	Homo sapiens	INH	%	50.0
	3333519	CHEMBL1166815	Inhibition of PKN1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3384	Homo sapiens	INH	%	50.0
	3334924	CHEMBL1166815	Inhibition of PKN1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3384	Homo sapiens	INH	%	50.0
	3336344	CHEMBL1166815	Inhibition of PKN1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3384	Homo sapiens	INH	%	50.0
	3341886	CHEMBL1166815	Inhibition of PKN1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	=	Inhibition	%	82.0	CHEMBL3384	Homo sapiens	INH	%	82.0
	3343333	CHEMBL1166815	Inhibition of PKN1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL3384	Homo sapiens	INH	%	50.0
	3358757	CHEMBL1175223	Inhibition of PKN1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	85.0	CHEMBL3384	Homo sapiens	INH	%	85.0
	3359199	CHEMBL1175223	Inhibition of PKN1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	28.0	CHEMBL3384	Homo sapiens	INH	%	28.0
	3443485	CHEMBL1244251	Inhibition of PRK1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	6.0	CHEMBL3384	Homo sapiens	INH	%	6.0
	3443702	CHEMBL1244251	Inhibition of PRK1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	5.0	CHEMBL3384	Homo sapiens	INH	%	5.0
	3444857	CHEMBL1244251	Inhibition of PRK1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	2.0	CHEMBL3384	Homo sapiens	INH	%	2.0
	3445258	CHEMBL1244930	Binding affinity to PKN1	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	5.3	CHEMBL3384	Homo sapiens	Kd	nM	5.3
	3445481	CHEMBL1244251	Inhibition of PRK1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	6.0	CHEMBL3384	Homo sapiens	INH	%	6.0
	3445698	CHEMBL1244251	Inhibition of PRK1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	1.0	CHEMBL3384	Homo sapiens	INH	%	1.0
	3445893	CHEMBL1244251	Inhibition of PRK1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	3.0	CHEMBL3384	Homo sapiens	INH	%	3.0
	3446083	CHEMBL1244251	Inhibition of PRK1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	-9.0	CHEMBL3384	Homo sapiens	INH	%	-9.0
	3448577	CHEMBL1244930	Binding affinity to PKN1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	3449015	CHEMBL1244930	Binding affinity to PKN1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	9.3	CHEMBL3384	Homo sapiens	Kd	nM	9.3
	3449307	CHEMBL1244930	Binding affinity to PKN1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	57.0	CHEMBL3384	Homo sapiens	Kd	nM	57.0
	3449308	CHEMBL1244930	Binding affinity to PKN1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	710.0	CHEMBL3384	Homo sapiens	Kd	nM	710.0
	3449808	CHEMBL1244930	Binding affinity to PKN1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	3450203	CHEMBL1244930	Binding affinity to PKN1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	uM	10.0
	3463318	CHEMBL1252620	Inhibition of PKN1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	100.0	CHEMBL3384	Homo sapiens	INH	%	100.0
	3463862	CHEMBL1252620	Inhibition of PKN1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	18.0	CHEMBL3384	Homo sapiens	INH	%	18.0
	3464081	CHEMBL1252620	Inhibition of PKN1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	84.0	CHEMBL3384	Homo sapiens	INH	%	84.0
	5152492	CHEMBL1656537	Inhibition of PKN1 by Caliper mobility shift assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	>	IC50	nM	10000.0	CHEMBL3384	Homo sapiens	IC50	uM	10.0
	5152517	CHEMBL1656537	Inhibition of PKN1 by Caliper mobility shift assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651521	>	IC50	nM	10000.0	CHEMBL3384	Homo sapiens	IC50	uM	10.0
Not Active	6307651	CHEMBL1816875	Inhibition of recombinant PRK1 assessed as 33Pi incorporation after 60 mins by scintillation counting	B	C=C[C@]1(C)C=C2[C@@H](O)[C@@H]3OC(=O)[C@@]4(C)CC[C@H]5C[C@]5([C@@H]34)[C@@]2(O)C(=O)C1		CHEMBL1812030		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	6307652	CHEMBL1816875	Inhibition of recombinant PRK1 assessed as 33Pi incorporation after 60 mins by scintillation counting	B	C=C[C@@]1(C)C=C2C(=O)C(O)=C3[C@](C)(C(=O)O)CC[C@@H]4C[C@]34[C@]2(O)C(=O)C1		CHEMBL516554		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
	6307653	CHEMBL1816875	Inhibition of recombinant PRK1 assessed as 33Pi incorporation after 60 mins by scintillation counting	B	Cc1cc(O)cc2oc3cc(O)cc(O)c3c(=O)c12		CHEMBL466154	=	IC50	nM	54900.0	CHEMBL3384	Homo sapiens	IC50	uM	54.9
	6307654	CHEMBL1816875	Inhibition of recombinant PRK1 assessed as 33Pi incorporation after 60 mins by scintillation counting	B	Cc1c(O)c(O)cc2oc3cc(O)cc(O)c3c(=O)c12		CHEMBL454440	=	IC50	nM	45300.0	CHEMBL3384	Homo sapiens	IC50	uM	45.3
	6340958	CHEMBL1827282	Activity of PKN1 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	94.0	CHEMBL3384	Homo sapiens	Activity	%	94.0
	6386322	CHEMBL1839919	Inhibition of recombinant PKN1	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL3384	Homo sapiens	IC50	uM	10.0
	7567152	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7567611	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7568082	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7568550	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7568982	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	1900.0	CHEMBL3384	Homo sapiens	Kd	nM	1900.0
	7569125	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7569585	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	170.0	CHEMBL3384	Homo sapiens	Kd	nM	170.0
	7570057	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7570520	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7571101	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7571558	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7572034	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7572471	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	710.0	CHEMBL3384	Homo sapiens	Kd	nM	710.0
	7573082	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7573539	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7574042	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7574450	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	340.0	CHEMBL3384	Homo sapiens	Kd	nM	340.0
	7575060	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	740.0	CHEMBL3384	Homo sapiens	Kd	nM	740.0
	7575521	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7575550	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	2400.0	CHEMBL3384	Homo sapiens	Kd	nM	2400.0
	7576015	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	9.3	CHEMBL3384	Homo sapiens	Kd	nM	9.3
	7576423	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7577034	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7577529	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7577999	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7578404	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	1100.0	CHEMBL3384	Homo sapiens	Kd	nM	1100.0
	7579424	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7579898	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	580.0	CHEMBL3384	Homo sapiens	Kd	nM	580.0
	7580367	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7580770	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7580958	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	210.0	CHEMBL3384	Homo sapiens	Kd	nM	210.0
	7581343	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7581788	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	3500.0	CHEMBL3384	Homo sapiens	Kd	nM	3500.0
	7582259	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7582723	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7583123	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1500.0	CHEMBL3384	Homo sapiens	Kd	nM	1500.0
	7583304	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7583701	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7584146	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7584617	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	5100.0	CHEMBL3384	Homo sapiens	Kd	nM	5100.0
	7585079	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	660.0	CHEMBL3384	Homo sapiens	Kd	nM	660.0
	7585483	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7585634	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7586042	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7586488	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7586959	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	350.0	CHEMBL3384	Homo sapiens	Kd	nM	350.0
	7587595	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7588014	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7588467	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7588947	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7589560	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7589984	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	5.3	CHEMBL3384	Homo sapiens	Kd	nM	5.3
	7590451	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7590483	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7590934	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7591533	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7591955	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	180.0	CHEMBL3384	Homo sapiens	Kd	nM	180.0
	7592458	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7592911	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7593500	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7593965	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7594438	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7594890	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	2900.0	CHEMBL3384	Homo sapiens	Kd	nM	2900.0
	7595470	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7595944	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	34.0	CHEMBL3384	Homo sapiens	Kd	nM	34.0
	7596415	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7596862	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7596998	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7597451	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7597924	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7598394	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3384	Homo sapiens	Kd	nM	10000.0
	7598836	CHEMBL1908442	Binding constant for PKN1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1.3	CHEMBL3384	Homo sapiens	Kd	nM	1.3
	7931125	CHEMBL1919462	Inhibition of PKN1 relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12	Outside typical range	CHEMBL1916891	=	Inhibition	%	-11.0	CHEMBL3384	Homo sapiens	INH	%	-11.0
	7951422	CHEMBL1926232	Inhibition of recombinant human PRK1	B	Cc1ccc(O)cc1CC[C@@H]1[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/CC(C)C		CHEMBL1922224	>	IC50	nM	100000.0	CHEMBL3384	Homo sapiens	IC50	uM	100.0
	7951423	CHEMBL1926232	Inhibition of recombinant human PRK1	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/CC(C)C		CHEMBL518060	>	IC50	nM	100000.0	CHEMBL3384	Homo sapiens	IC50	uM	100.0
	7951424	CHEMBL1926232	Inhibition of recombinant human PRK1	B	C=C(CC[C@@H](C)[C@H]1CC[C@H]2[C@H](CCc3cc(O)ccc3C)C(=O)CC[C@@]21C)C(C)C		CHEMBL1922225	>	IC50	nM	100000.0	CHEMBL3384	Homo sapiens	IC50	uM	100.0
	7951425	CHEMBL1926232	Inhibition of recombinant human PRK1	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C		CHEMBL456936	>	IC50	nM	100000.0	CHEMBL3384	Homo sapiens	IC50	uM	100.0
	7951426	CHEMBL1926232	Inhibition of recombinant human PRK1	B	Cc1ccc(O)cc1CC[C@H]1[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC[C@H]1O		CHEMBL517956	>	IC50	nM	100000.0	CHEMBL3384	Homo sapiens	IC50	uM	100.0
	7951427	CHEMBL1926232	Inhibition of recombinant human PRK1	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1C[C@H](O)[C@@H]2[C@H](C)CCCC(C)C		CHEMBL456294	>	IC50	nM	100000.0	CHEMBL3384	Homo sapiens	IC50	uM	100.0
	7951428	CHEMBL1926232	Inhibition of recombinant human PRK1	B	C=C(CC[C@@H](C)[C@H]1CC[C@H]2[C@H](CCc3cc(O)ccc3C)[C@H](O)CC[C@@]21C)C(C)C		CHEMBL515982	>	IC50	nM	100000.0	CHEMBL3384	Homo sapiens	IC50	uM	100.0
	7951429	CHEMBL1926232	Inhibition of recombinant human PRK1	B	Cc1ccc(O)cc1CC[C@H]1[C@@H]2C[C@H](O)[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC[C@H]1O		CHEMBL464351	>	IC50	nM	100000.0	CHEMBL3384	Homo sapiens	IC50	uM	100.0
	8013074	CHEMBL1947861	Inhibition of PKN1 using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	=	IC50	nM	310.0	CHEMBL3384	Homo sapiens	IC50	uM	0.31
	10839467	CHEMBL2015498	Inhibition of PKN1 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	52.0	CHEMBL3384	Homo sapiens	INH	%	52.0
Not Active	10912563	CHEMBL2038046	Inhibition of recombinant PRK1 at <10 uM by radiometric kinase assay	B	Cn1c(=O)c2ccc(-c3nc4ccccc4n3C)nc2n(C)c1=O		CHEMBL2036871		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	10913473	CHEMBL2038046	Inhibition of recombinant PRK1 at <10 uM by radiometric kinase assay	B	Cn1c(-c2ccnc(Nc3ccccc3)n2)nc2ccccc21		CHEMBL2036725		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	10913489	CHEMBL2038046	Inhibition of recombinant PRK1 at <10 uM by radiometric kinase assay	B	Cc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1		CHEMBL2036726		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	10913505	CHEMBL2038046	Inhibition of recombinant PRK1 at <10 uM by radiometric kinase assay	B	Cn1c(-c2ccnc(Nc3ccc(Cl)cc3)n2)nc2ccccc21		CHEMBL2036727		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	10913521	CHEMBL2038046	Inhibition of recombinant PRK1 at <10 uM by radiometric kinase assay	B	Cn1c(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)nc2ccccc21		CHEMBL2036728		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	10913537	CHEMBL2038046	Inhibition of recombinant PRK1 at <10 uM by radiometric kinase assay	B	CCOc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1		CHEMBL2036867		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	10913553	CHEMBL2038046	Inhibition of recombinant PRK1 at <10 uM by radiometric kinase assay	B	COc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1		CHEMBL2036868		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
	12035214	CHEMBL2150557	Inhibition of PKN1 at 1 uM	B	C[C@H](N)CNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147537	>	Inhibition	%	80.0	CHEMBL3384	Homo sapiens	INH	%	80.0
	12047331	CHEMBL2157750	Inhibition of PRK1 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1	Outside typical range	CHEMBL2152768	=	Inhibition	%	-13.6	CHEMBL3384	Homo sapiens	INH	%	-13.6
Not Active	12047555	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3Cl)cc1CC2		CHEMBL2152781		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048346	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3C(F)(F)F)cc1CC2		CHEMBL2152782		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048361	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3Cl)cc1CC2		CHEMBL2152785		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048376	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3C)cc1CC2		CHEMBL2152786		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048391	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(C(F)(F)F)cc3N)cc1CC2		CHEMBL2152787		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048406	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(C)c3)cc1CC2		CHEMBL2152788		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048421	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3cc(F)cc(F)c3F)cc1CC2		CHEMBL2152789		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048436	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(-c3ccccc3)cc1CC2		CHEMBL2152791		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048451	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	COc1ccc2ccc3cc(Nc4ccc(F)cc4F)ccc3c(=O)c2c1		CHEMBL2152792		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048466	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	CC1(C)OC[C@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccccc4N)cc2CC3)O1		CHEMBL2152798		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048481	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)CCc1ccc(OC[C@H](O)CO)cc1C2=O		CHEMBL2152936		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048496	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	Nc1ccccc1Nc1ccc2c(=O)c3cc(OCCN4CCOCC4)ccc3ccc2c1		CHEMBL2152939		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048511	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCO)cc21		CHEMBL2152940		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048526	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCCO)cc21		CHEMBL2152941		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048541	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC3CCOCC3)cc21		CHEMBL2152942		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048556	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	CC1(C)OC[C@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)O1		CHEMBL2152943		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048571	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@@H](O)CO)cc21		CHEMBL2152946		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048586	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	CC1(C)OC[C@@H](CCOc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)O1		CHEMBL2152947		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048601	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCCN3CCOCC3)cc21		CHEMBL2152950		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048616	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	CC1(C)OC[C@H](COc2ccc3c(c2)CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL2152957		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048631	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OC[C@H](O)CO)ccc21		CHEMBL2152958		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048646	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	CC1(C)OC[C@@H](COc2ccc3c(c2)CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL2152959		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048661	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OC[C@@H](O)CO)ccc21		CHEMBL2152960		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12048676	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	COc1cccc2c1CCc1cc(Nc3ccc(F)cc3F)ccc1C2=O		CHEMBL2152965		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12049620	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(O)cccc21		CHEMBL2152966		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12049635	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c1cccc2C1CCOCC1		CHEMBL2152967		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12049650	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	CC1(C)OC[C@H](COc2cccc3c2CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL2152968		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12049665	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(OC[C@H](O)CO)cccc21		CHEMBL2152969		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12049680	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(OCCN3CCOCC3)cccc21		CHEMBL2152970		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12049695	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	COc1cccc2c1CCc1cc(Nc3ccccc3N)ccc1C2=O		CHEMBL2152971		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12049710	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	CC1(C)OC[C@H](COc2cccc3c2CCc2cc(Nc4ccccc4N)ccc2C3=O)O1		CHEMBL2152972		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	12049725	CHEMBL2155709	Inhibition of PRK1 at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)CCc1c(OC[C@H](O)CO)cccc1C2=O		CHEMBL2152973		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
	12150576	CHEMBL2188512	Inhibition of human recombinant PKN1 by radiometric kinase assay	B	CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1		CHEMBL2178352	=	IC50	nM	6100.0	CHEMBL3384	Homo sapiens	IC50	uM	6.1
	12172260	CHEMBL2212490	Inhibition of PKN1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL3384	Homo sapiens	Activity	%	100.0
	12183833	CHEMBL2211990	Inhibition of PKN1	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL3384	Homo sapiens	pIC50		5.0
	12727677	CHEMBL2351141	Inhibition of PRK1 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	93.0	CHEMBL3384	Homo sapiens	Activity	%	93.0
	12728963	CHEMBL2349897	Inhibition of PRK1 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	113.0	CHEMBL3384	Homo sapiens	Activity	%	113.0
	12730106	CHEMBL2351141	Inhibition of PRK1 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	110.0	CHEMBL3384	Homo sapiens	Activity	%	110.0
	13374389	CHEMBL2406520	Inhibition of PRK1 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	7.0	CHEMBL3384	Homo sapiens	INH	%	7.0
	13439779	CHEMBL2429020	Competitive binding affinity to PKN1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL3384	Homo sapiens	INH	%	50.0
	13445612	CHEMBL2429020	Competitive binding affinity to PKN1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL3384	Homo sapiens	INH	%	50.0
	13451599	CHEMBL2429020	Competitive binding affinity to PKN1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL3384	Homo sapiens	INH	%	50.0
	13878358	CHEMBL3108317	Inhibition of PRK1 (unknown origin)	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	IC50	nM	5800.0	CHEMBL3384	Homo sapiens	IC50	uM	5.8
	13878359	CHEMBL3108317	Inhibition of PRK1 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.0	CHEMBL3384	Homo sapiens	IC50	uM	0.001
	13878360	CHEMBL3108317	Inhibition of PRK1 (unknown origin)	B	Cc1c(O)c(O)c(O)c(C=O)c1-c1cc2c(C=O)c(C)c(O)c(O)c2o1		CHEMBL3104855	=	IC50	nM	9000.0	CHEMBL3384	Homo sapiens	IC50	uM	9.0
	13878361	CHEMBL3108317	Inhibition of PRK1 (unknown origin)	B	Cc1c(O)c(O)c(O)c2c1COC2=O		CHEMBL3104854	=	IC50	nM	18600.0	CHEMBL3384	Homo sapiens	IC50	uM	18.6
	13878362	CHEMBL3108317	Inhibition of PRK1 (unknown origin)	B	COCc1c(C)c(O)c(O)c(O)c1C=O		CHEMBL3104853	>	IC50	nM	30000.0	CHEMBL3384	Homo sapiens	IC50	uM	30.0
	13878363	CHEMBL3108317	Inhibition of PRK1 (unknown origin)	B	COC1OC(=O)c2c(O)c(O)c(O)c(C)c21		CHEMBL3104852	>	IC50	nM	30000.0	CHEMBL3384	Homo sapiens	IC50	uM	30.0
	13878364	CHEMBL3108317	Inhibition of PRK1 (unknown origin)	B	Cc1c(O)c(O)c2c(c1C=O)[C@@H]1O[C@H](O2)c2c(C)c(O)c(O)c(O)c2C1=O		CHEMBL3104851	=	IC50	nM	4480.0	CHEMBL3384	Homo sapiens	IC50	uM	4.48
	13897439	CHEMBL3111636	Inhibition of recombinant PRK1 (unknown origin) using casein as substrate assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	COC(=O)c1cc(O)c(O)c(C[C@]2(C)[C@@H](C)CC[C@@]3(C)C(C)=CCC[C@H]32)c1		CHEMBL3109404	>	IC50	nM	100000.0	CHEMBL3384	Homo sapiens	IC50	uM	100.0
	13897440	CHEMBL3111636	Inhibition of recombinant PRK1 (unknown origin) using casein as substrate assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	COc1cc2nc(C)oc2c(C[C@]2(C)[C@@H](C)CC[C@@]3(C)C(C)=CCC[C@H]32)c1O		CHEMBL3109402	>	IC50	nM	100000.0	CHEMBL3384	Homo sapiens	IC50	uM	100.0
	13897441	CHEMBL3111636	Inhibition of recombinant PRK1 (unknown origin) using casein as substrate assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	CC1=CCC[C@@H]2[C@@]1(C)CC[C@H](C)[C@@]2(C)CC1=C(O)C(=O)C=C(NCCC(C)C)C1=O		CHEMBL3109401	>	IC50	nM	100000.0	CHEMBL3384	Homo sapiens	IC50	uM	100.0
	14545801	CHEMBL3224471	Inhibition of PKN1 (unknown origin) assessed as residual activity at 1 uM	B	CS(=O)(=O)O.O=C(NCc1cccc(O)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL3218297	=	Activity	%	19.5	CHEMBL3384	Homo sapiens	Activity	%	19.5
	14545825	CHEMBL3224501	Inhibition of PKN1 (unknown origin)	B	CS(=O)(=O)O.O=C(NCc1cccc(O)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL3218297	<	IC50	nM	1.0	CHEMBL3384	Homo sapiens	IC50	nM	1.0
	15018681	CHEMBL3361573	Inhibition of PRK1 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	25.1	CHEMBL3384	Homo sapiens	INH	%	25.1
	15077419	CHEMBL3387550	Inhibition of PKN-1 (unknown origin)	B	NCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL1214929	=	IC50	nM	7.0	CHEMBL3384	Homo sapiens	IC50	nM	7.0
	15077420	CHEMBL3387550	Inhibition of PKN-1 (unknown origin)	B	CC(C)(N)CNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147538	=	IC50	nM	35.0	CHEMBL3384	Homo sapiens	IC50	nM	35.0
	15077421	CHEMBL3387550	Inhibition of PKN-1 (unknown origin)	B	CC(C)(N)CNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL3338837	=	IC50	nM	99.0	CHEMBL3384	Homo sapiens	IC50	nM	99.0
	15077422	CHEMBL3387550	Inhibition of PKN-1 (unknown origin)	B	CC(C)(N)CNc1nc(-c2ccc3[nH]ncc3c2)nc2cnccc12		CHEMBL3338838	=	IC50	nM	547.0	CHEMBL3384	Homo sapiens	IC50	nM	547.0
	15077423	CHEMBL3387550	Inhibition of PKN-1 (unknown origin)	B	c1cc2c(N3CCNCC3)nc(-c3ccc4[nH]ncc4c3)nc2cn1		CHEMBL3338839	>	IC50	nM	1000.0	CHEMBL3384	Homo sapiens	IC50	nM	1000.0
	15077424	CHEMBL3387550	Inhibition of PKN-1 (unknown origin)	B	c1ccc2c(N3CCNCC3)nc(-c3ccc4[nH]ncc4c3)nc2c1		CHEMBL3338840	=	IC50	nM	990.0	CHEMBL3384	Homo sapiens	IC50	nM	990.0
	15077425	CHEMBL3387550	Inhibition of PKN-1 (unknown origin)	B	c1ccc2c(N3CCNCC3)nc(-c3ccc4[nH]ncc4c3)cc2c1		CHEMBL3338841	>	IC50	nM	1000.0	CHEMBL3384	Homo sapiens	IC50	nM	1000.0
	15077426	CHEMBL3387550	Inhibition of PKN-1 (unknown origin)	B	NCCNc1nc(-c2ccc3[nH]ncc3c2)nc2ccccc12		CHEMBL3338842	>	IC50	nM	1000.0	CHEMBL3384	Homo sapiens	IC50	nM	1000.0
	15077427	CHEMBL3387550	Inhibition of PKN-1 (unknown origin)	B	NCCCNc1nc(-c2ccc3[nH]ncc3c2)nc2ccccc12		CHEMBL3338843	>	IC50	nM	1000.0	CHEMBL3384	Homo sapiens	IC50	nM	1000.0
	15077428	CHEMBL3387550	Inhibition of PKN-1 (unknown origin)	B	CN1CCN(c2nc(-c3ccc4[nH]ncc4c3)nc3ccccc23)CC1		CHEMBL3338844	>	IC50	nM	1000.0	CHEMBL3384	Homo sapiens	IC50	nM	1000.0
Active	15246255	CHEMBL3427912	Inhibition of human full length N-terminal GST-tagged PRK1 expressed in insect cells using glycogen synthase derived peptide as substrate at 100 nM by radiometric assay in presence of [32P]ATP	B	COC(=O)c1ccc(NC(=O)c2cccc(-c3cc(C(=O)Nc4ccncc4F)ccc3CN)c2)cc1		CHEMBL3426624		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
	15756841	CHEMBL3630942	Inhibition of PKN1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	25.07	CHEMBL3384	Homo sapiens	INH	%	25.07
	15757882	CHEMBL3630942	Inhibition of PKN1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	5.55	CHEMBL3384	Homo sapiens	INH	%	5.55
	15758861	CHEMBL3630942	Inhibition of PKN1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	10.64	CHEMBL3384	Homo sapiens	INH	%	10.64
	16421962	CHEMBL3749781	Inhibition of PKN1 (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	=	IC50	nM	4900.0	CHEMBL3384	Homo sapiens	IC50	uM	4.9
	16425391	CHEMBL3751062	Inhibition of PRK1 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-3.7	CHEMBL3384	Homo sapiens	INH	%	-3.7
	16431977	CHEMBL3750016	Inhibition of human PKN1 using [KKLNRTLSVA] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL3384	Homo sapiens	IC50	uM	10.0
	16451589	CHEMBL3761170	Inhibition of PRK1 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	3.7	CHEMBL3384	Homo sapiens	INH	%	3.7
	16525652	CHEMBL3790302	Inhibition of PKN1 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	2600.0	CHEMBL3384	Homo sapiens	IC50	uM	2.6
	16525653	CHEMBL3790302	Inhibition of PKN1 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3785500	=	IC50	nM	9700.0	CHEMBL3384	Homo sapiens	IC50	uM	9.7
	16525654	CHEMBL3790302	Inhibition of PKN1 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1		CHEMBL3786167	>	IC50	nM	10000.0	CHEMBL3384	Homo sapiens	IC50	uM	10.0
	16525655	CHEMBL3790302	Inhibition of PKN1 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL3384	Homo sapiens	IC50	uM	10.0
	16614607	CHEMBL3815963	Inhibition of human PKN1 at 1 uM using [KKLNRTLSVA] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	3.0	CHEMBL3384	Homo sapiens	INH	%	3.0
	16618126	CHEMBL3816512	Inhibition of full length recombinant human GST-tagged PRK1 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL3384	Homo sapiens	INH	%	50.0
	16621529	CHEMBL3820668	Inhibition of PKN1 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL3384	Homo sapiens	IC50	nM	30000.0
	16622236	CHEMBL3820668	Inhibition of PKN1 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.2	CHEMBL3384	Homo sapiens	IC50	nM	1.2
	16837457	CHEMBL3876119	Inhibition of human recombinant full length GST-tagged PKN1 expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	10000.0	CHEMBL3384	Homo sapiens	IC50	nM	10000.0
Inactive	17927089	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927090	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927091	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927092	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927093	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927094	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927095	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927096	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927097	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927098	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Kd	nM	7959.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	7959.0
Active	17927099	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	=	Kd	nM	19.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	19.0
Inactive	17927100	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927101	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927102	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927103	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927104	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927105	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927106	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927107	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927108	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927109	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927110	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927111	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927112	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927113	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927114	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927115	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927116	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927117	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927118	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927119	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927120	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927121	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	244.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	244.0
Inactive	17927122	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927123	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927124	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927125	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927126	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927127	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927128	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927129	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927130	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927131	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927132	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	189.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	189.0
Inactive	17927133	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927134	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927135	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927136	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927137	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927138	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927139	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	1167.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	1167.0
Inactive	17927140	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927141	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927142	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927143	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927144	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927145	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	58.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	58.0
Active	17927146	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Kd	nM	841.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	841.0
Active	17927147	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	Kd	nM	20414.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	20414.0
Inactive	17927148	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927149	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927150	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	165.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	165.0
Inactive	17927151	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927152	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927153	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927154	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927155	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927156	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927157	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927158	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	=	Kd	nM	49813.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	49813.0
Inactive	17927159	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927160	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927161	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927162	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927163	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927164	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927165	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927166	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927167	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927168	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927169	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17927170	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Kd	nM	2954.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	2954.0
Active	17927171	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	11.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	11.0
Inactive	17927172	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927173	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927174	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927175	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927176	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927177	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927178	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927179	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927180	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927181	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927182	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927183	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927184	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927185	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927186	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	39.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	39.0
Inactive	17927187	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927188	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927189	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927190	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927191	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927192	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927193	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927194	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927195	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927196	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927197	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	198.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	198.0
Inactive	17927198	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927199	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927200	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	8.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	8.0
Inactive	17927201	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927202	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927203	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	=	Kd	nM	1577.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	1577.0
Inactive	17927204	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927205	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927206	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	2159.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	2159.0
Active	17927207	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	359.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	359.0
Inactive	17927208	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927209	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	3050.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	3050.0
Active	17927210	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	8994.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	8994.0
Inactive	17927211	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927212	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927213	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927214	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927215	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927216	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927217	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	=	Kd	nM	76.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	76.0
Inactive	17927218	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927219	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927220	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927221	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927222	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927223	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927224	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927225	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927226	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927227	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927228	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	3088.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	3088.0
Inactive	17927229	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927230	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927231	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927232	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	2940.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	2940.0
Inactive	17927233	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927234	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927235	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927236	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927237	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927238	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927239	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	=	Kd	nM	1689.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	1689.0
Inactive	17927240	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927241	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927242	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927243	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927244	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927245	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927246	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927247	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927248	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	=	Kd	nM	253.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	253.0
Inactive	17927249	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927250	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927251	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927252	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927253	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927254	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927255	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927256	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927257	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927258	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	2983.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	2983.0
Active	17927259	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	119.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	119.0
Inactive	17927260	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927261	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927262	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927263	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927264	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927265	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927266	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927267	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927268	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927269	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927270	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927271	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927272	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927273	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	9598.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	9598.0
Inactive	17927274	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927275	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927276	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	=	Kd	nM	416.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	416.0
Inactive	17927277	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927278	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927279	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927280	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927281	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927282	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927283	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	13159.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	13159.0
Inactive	17927284	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927285	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927286	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927287	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927288	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927289	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927290	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927291	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927292	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	264.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	264.0
Inactive	17927293	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927294	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927295	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927296	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927297	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	1344.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	1344.0
Inactive	17927298	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927299	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	=	Kd	nM	2925.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	2925.0
Active	17927300	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	=	Kd	nM	25.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	25.0
Inactive	17927301	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927302	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927303	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927304	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927305	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927306	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927307	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927308	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927309	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927310	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927311	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927312	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927313	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927314	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927315	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927316	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927317	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927318	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927319	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927320	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927321	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927322	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	=	Kd	nM	35424.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	35424.0
Inactive	17927323	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927324	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Active	17927325	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	=	Kd	nM	880.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	880.0
Active	17927326	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	=	Kd	nM	104.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	104.0
Inactive	17927327	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927328	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927329	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927330	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17927331	CHEMBL3991830	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL3384	Homo sapiens	Kd apparent	nM	30000.0
	18114801	CHEMBL4025331	Inhibition of wild-type human partial length PKN1 (E598 to C948 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL3384	Homo sapiens	Activity	%	100.0
	18153234	CHEMBL4034468	Inhibition of PKN1 Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1	Outside typical range	CHEMBL4084955	=	Inhibition	%	-12.4	CHEMBL3384	Homo sapiens	INH	%	-12.4
	18203855	CHEMBL4044142	Inhibition of wild-type human partial length PKN1 (E598 to C948 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	92.0	CHEMBL3384	Homo sapiens	Activity	%	92.0
	18211713	CHEMBL4045809	Inhibition of PKN1 conserved Lys1 (VLLSEFRPSGELFAIKALK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-70.2	CHEMBL3384	Homo sapiens	INH	%	-70.2
	18211954	CHEMBL4046050	Inhibition of PKN1 conserved Lys1 (VLLSEFRPSGELFAIKALK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-50.3	CHEMBL3384	Homo sapiens	INH	%	-50.3
	18253207	CHEMBL4054891	Inhibition of human PKN1 (E598 to C948 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by KINOMEscan assay relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	0.3	CHEMBL3384	Homo sapiens	Activity	%	0.3
	18253208	CHEMBL4054891	Inhibition of human PKN1 (E598 to C948 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by KINOMEscan assay relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	7.0	CHEMBL3384	Homo sapiens	Activity	%	7.0
	18282212	CHEMBL4120167	Inhibition of full length recombinant GST-tagged human PRK1 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	5.3	CHEMBL3384	Homo sapiens	INH	%	5.3
	18282531	CHEMBL4120167	Inhibition of full length recombinant GST-tagged human PRK1 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	-8.0	CHEMBL3384	Homo sapiens	INH	%	-8.0
	18440397	CHEMBL4157221	Binding affinity to wild-type human partial length PKN1 (E598 to C948 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	86.0	CHEMBL3384	Homo sapiens	Activity	%	86.0
	18484353	CHEMBL4186000	Binding affinity to wild-type human partial length PKN1 (E598 to C948 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	82.0	CHEMBL3384	Homo sapiens	Activity	%	82.0
	18484837	CHEMBL4186000	Binding affinity to wild-type human partial length PKN1 (E598 to C948 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL3384	Homo sapiens	Activity	%	100.0
	18507635	CHEMBL4191156	Inhibition of recombinant human PRK1 (498 to end residues) at 1 uM using KKLNRTLSFAEPG as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-1.0	CHEMBL3384	Homo sapiens	INH	%	-1.0
	18653415	CHEMBL4230196	Inhibition of PKN1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	-2.0	CHEMBL3384	Homo sapiens	INH	%	-2.0
	18653416	CHEMBL4230196	Inhibition of PKN1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	6.0	CHEMBL3384	Homo sapiens	INH	%	6.0
	18655335	CHEMBL4230900	Binding affinity to wild-type human partial length PKN1 (E598 to C948 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL3384	Homo sapiens	Activity	%	100.0
	18726763	CHEMBL4259287	Inhibition of PKN1 (unknown origin) at 10 uM	B	Oc1ccc(C2=NN(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)C2)cc1O		CHEMBL4283413	=	Inhibition	%	11.0	CHEMBL3384	Homo sapiens	INH	%	11.0
	18751209	CHEMBL4263918	Inhibition of PKN1 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	4.0	CHEMBL3384	Homo sapiens	INH	%	4.0
	18752152	CHEMBL4264489	Binding affinity to wild-type human partial length PKN1 (E598 to C948 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	87.0	CHEMBL3384	Homo sapiens	Activity	%	87.0
	18858152	CHEMBL4307998	Binding affinity to wild-type human partial length PKN1 (E598 to C948 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL3384	Homo sapiens	Activity	%	100.0
	18892952	CHEMBL4314918	Inhibition of human PRK1 V901I mutant (498 to end residues) using KKLNRTLSFAEPG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	98.5	CHEMBL3384	Homo sapiens	Activity	%	98.5
	18919548	CHEMBL4322904	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged PKN1 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	11.0	CHEMBL3384	Homo sapiens	Kd	nM	11.0
	18919736	CHEMBL4322904	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged PKN1 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	6.0	CHEMBL3384	Homo sapiens	Kd	nM	6.0
	18938245	CHEMBL4327849	Inhibition of human PKN1 assessed as residual activity at 1 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	102.04	CHEMBL3384	Homo sapiens	Activity	%	102.04
	18938246	CHEMBL4327849	Inhibition of human PKN1 assessed as residual activity at 1 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	87.75	CHEMBL3384	Homo sapiens	Activity	%	87.75
	18938694	CHEMBL4328213	Inhibition of human PKN1 assessed as residual activity at 100 uM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL3384	Homo sapiens	Activity	%	65.0
	18939078	CHEMBL4328577	Inhibition of human PKN1 using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.78	CHEMBL3384	Homo sapiens	IC50	10'-9M	3.78
	18958608	CHEMBL4333583	Binding affinity to wild-type human partial length PKN1 (E598 to C948 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	56.0	CHEMBL3384	Homo sapiens	Activity	%	56.0
	18964634	CHEMBL4335258	Inhibition of recombinant human PRK1 V901I mutant (498 to end residues) assessed as residual activity at 1 uM using KKLNRTLSFAEPG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	90.0	CHEMBL3384	Homo sapiens	Activity	%	90.0
	18964635	CHEMBL4335258	Inhibition of recombinant human PRK1 V901I mutant (498 to end residues) assessed as residual activity at 1 uM using KKLNRTLSFAEPG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	98.0	CHEMBL3384	Homo sapiens	Activity	%	98.0
	18972071	CHEMBL4337081	Inhibition of recombinant human PRK1 V901I mutant (498 to end residues) assessed as residual activity at 10 uM using KKLNRTLSFAEPG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	60.0	CHEMBL3384	Homo sapiens	Activity	%	60.0
	19021552	CHEMBL4347774	Inhibition of recombinant human PKN1 at 20 nM using CREBtide as substrate measured after 15 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	11.0	CHEMBL3384	Homo sapiens	INH	%	11.0
	19021553	CHEMBL4347775	Inhibition of recombinant human PKN1 at 200 nM using CREBtide as substrate measured after 15 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	33.0	CHEMBL3384	Homo sapiens	INH	%	33.0
Not Active	19040129	CHEMBL4352032	Inhibition of human PRK1 V901I mutant (498 to end residues) using KKLNRTLSFAEPG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Active	19041255	CHEMBL4352516	Inhibition of human PKN1 at 10 uM using KKLNRTLSVA as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
	19059777	CHEMBL4358078	Binding affinity to wild-type human partial length PKN1 (E598 to C948 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	83.0	CHEMBL3384	Homo sapiens	Activity	%	83.0
	19090341	CHEMBL4365915	Inhibition of wild-type human partial length PKN1 (E598 to C948 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL3384	Homo sapiens	Activity	%	100.0
	19092088	CHEMBL4366562	Inhibition of human PKN1 at 100 nM using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	16.76	CHEMBL3384	Homo sapiens	INH	%	16.76
	19144818	CHEMBL4377834	Inhibition of human PRK1 V901I mutant (498 to end residues) at 1 uM using KKLNRTLSFAEPG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	3.0	CHEMBL3384	Homo sapiens	INH	%	3.0
	19146963	CHEMBL4378829	Inhibition of human PRK1 V901I mutant (498 to end residues) at 10 uM using KKLNRTLSFAEPG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	2.0	CHEMBL3384	Homo sapiens	INH	%	2.0
	19148013	CHEMBL4379409	Inhibition of recombinant human PRK1 V901I (498 to end residues) using KKLNRTLSFAEPG as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL3384	Homo sapiens	IC50	uM	10.0
	19159605	CHEMBL4382709	Binding affinity to wild-type human partial length PKN1 (E598 to C948 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	41.0	CHEMBL3384	Homo sapiens	Activity	%	41.0
	19181126	CHEMBL4387337	Inhibition of recombinant full length human GST-tagged PRK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	7.0	CHEMBL3384	Homo sapiens	INH	%	7.0
	19181351	CHEMBL4387337	Inhibition of recombinant full length human GST-tagged PRK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	8.5	CHEMBL3384	Homo sapiens	INH	%	8.5
	19191402	CHEMBL4389428	Inhibition of wild-type human partial length PKN1 (E598 to C948 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL3384	Homo sapiens	INH	%	100.0
	19192091	CHEMBL4389905	Inhibition of wild-type human partial length PKN1 (E598 to C948 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	80.0	CHEMBL3384	Homo sapiens	INH	%	80.0
	19200347	CHEMBL4391531	Binding affinity to wild-type human partial length PKN1 (E598 to C948 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	18.0	CHEMBL3384	Homo sapiens	Activity	%	18.0
	19266582	CHEMBL4405532	Inhibition of wild-type human partial length PKN1 (E598 to C948 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL3384	Homo sapiens	INH	%	50.0
	19476618	CHEMBL4479766	Inhibition of full-length recombinant human GST-tagged PKN1 expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	3900.0	CHEMBL3384	Homo sapiens	IC50	nM	3900.0
	19476718	CHEMBL4479766	Inhibition of full-length recombinant human GST-tagged PKN1 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	18000.0	CHEMBL3384	Homo sapiens	IC50	nM	18000.0
	19476818	CHEMBL4479766	Inhibition of full-length recombinant human GST-tagged PKN1 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	250.0	CHEMBL3384	Homo sapiens	IC50	nM	250.0
	19476918	CHEMBL4479766	Inhibition of full-length recombinant human GST-tagged PKN1 expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	17000.0	CHEMBL3384	Homo sapiens	IC50	nM	17000.0
	20600632	CHEMBL4603584	Inhibition of recombinant full length GST-tagged human PKN1 expressed in baculovirus expression system using Ser/Thr 07 as substrate in presence of ATP after 1 hr by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL3384	Homo sapiens	IC50	uM	100.0
	20706230	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	=	IC50	nM	1100.0	CHEMBL3384	Homo sapiens	IC50	uM	1.1
	20706231	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	COC(=O)Cn1c(-c2ccncc2)nc2c(C(N)=O)cccc21		CHEMBL4636367	=	IC50	nM	52840.0	CHEMBL3384	Homo sapiens	IC50	uM	52.84
	20706232	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	NC(=O)c1cccc2[nH]c(-c3cccnc3)nc12		CHEMBL185288	=	IC50	nM	66290.0	CHEMBL3384	Homo sapiens	IC50	uM	66.29
	20706233	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	NC(=O)c1cccc2[nH]c(-c3cncnc3)nc12	Outside typical range	CHEMBL4640475	=	IC50	nM	137920.0	CHEMBL3384	Homo sapiens	IC50	uM	137.92
	20706234	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	COc1cc(-c2nc3c(C(N)=O)cccc3[nH]2)ccn1		CHEMBL4645636	=	IC50	nM	61590.0	CHEMBL3384	Homo sapiens	IC50	uM	61.59
	20706235	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	CNC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL4635777	=	IC50	nM	10590.0	CHEMBL3384	Homo sapiens	IC50	uM	10.59
	20706236	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	CN(C)C(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL4649365	=	IC50	nM	56660.0	CHEMBL3384	Homo sapiens	IC50	uM	56.66
	20706237	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	NC(=O)c1ccc2[nH]c(-c3ccncc3)nc2c1		CHEMBL4637286	=	IC50	nM	99410.0	CHEMBL3384	Homo sapiens	IC50	uM	99.41
	20706238	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	c1ccc2[nH]c(-c3ccncc3)nc2c1		CHEMBL379376	=	IC50	nM	45540.0	CHEMBL3384	Homo sapiens	IC50	uM	45.54
	20706239	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	O=[N+]([O-])c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL4646744	=	IC50	nM	58940.0	CHEMBL3384	Homo sapiens	IC50	uM	58.94
	20706240	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	COC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL4632420	=	IC50	nM	38810.0	CHEMBL3384	Homo sapiens	IC50	uM	38.81
	20706241	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	CCOC(=O)c1ccc2[nH]c(-c3ccncc3)nc2c1		CHEMBL4638916	=	IC50	nM	56690.0	CHEMBL3384	Homo sapiens	IC50	uM	56.69
	20706242	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	N#Cc1ccc2[nH]c(-c3ccncc3)nc2c1		CHEMBL4634210	=	IC50	nM	38540.0	CHEMBL3384	Homo sapiens	IC50	uM	38.54
	20706243	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	O=[N+]([O-])c1ccc2[nH]c(-c3ccncc3)nc2c1	Outside typical range	CHEMBL160012	=	IC50	nM	109300.0	CHEMBL3384	Homo sapiens	IC50	uM	109.3
	20706244	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	NC(=O)c1cc(Br)cc2[nH]c(-c3ccncc3)nc12		CHEMBL4647033	=	IC50	nM	4450.0	CHEMBL3384	Homo sapiens	IC50	uM	4.45
	20706245	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	=	Ki	nM	540.0	CHEMBL3384	Homo sapiens	Ki	uM	0.54
	20706246	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	COC(=O)Cn1c(-c2ccncc2)nc2c(C(N)=O)cccc21		CHEMBL4636367	=	Ki	nM	25940.0	CHEMBL3384	Homo sapiens	Ki	uM	25.94
	20706247	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	NC(=O)c1cccc2[nH]c(-c3cccnc3)nc12		CHEMBL185288	=	Ki	nM	32540.0	CHEMBL3384	Homo sapiens	Ki	uM	32.54
	20706248	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	NC(=O)c1cccc2[nH]c(-c3cncnc3)nc12		CHEMBL4640475	=	Ki	nM	67710.0	CHEMBL3384	Homo sapiens	Ki	uM	67.71
	20706249	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	COc1cc(-c2nc3c(C(N)=O)cccc3[nH]2)ccn1		CHEMBL4645636	=	Ki	nM	30230.0	CHEMBL3384	Homo sapiens	Ki	uM	30.23
	20706250	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	CNC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL4635777	=	Ki	nM	5200.0	CHEMBL3384	Homo sapiens	Ki	uM	5.2
	20706251	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	CN(C)C(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL4649365	=	Ki	nM	27810.0	CHEMBL3384	Homo sapiens	Ki	uM	27.81
	20706252	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	NC(=O)c1ccc2[nH]c(-c3ccncc3)nc2c1		CHEMBL4637286	=	Ki	nM	48800.0	CHEMBL3384	Homo sapiens	Ki	uM	48.8
	20706253	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	c1ccc2[nH]c(-c3ccncc3)nc2c1		CHEMBL379376	=	Ki	nM	22360.0	CHEMBL3384	Homo sapiens	Ki	uM	22.36
	20706254	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	O=[N+]([O-])c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL4646744	=	Ki	nM	28930.0	CHEMBL3384	Homo sapiens	Ki	uM	28.93
	20706255	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	COC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL4632420	=	Ki	nM	19050.0	CHEMBL3384	Homo sapiens	Ki	uM	19.05
	20706256	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	CCOC(=O)c1ccc2[nH]c(-c3ccncc3)nc2c1		CHEMBL4638916	=	Ki	nM	27830.0	CHEMBL3384	Homo sapiens	Ki	uM	27.83
	20706257	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	N#Cc1ccc2[nH]c(-c3ccncc3)nc2c1		CHEMBL4634210	=	Ki	nM	18920.0	CHEMBL3384	Homo sapiens	Ki	uM	18.92
	20706258	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	O=[N+]([O-])c1ccc2[nH]c(-c3ccncc3)nc2c1		CHEMBL160012	=	Ki	nM	53660.0	CHEMBL3384	Homo sapiens	Ki	uM	53.66
	20706259	CHEMBL4628249	Displacement of tracer from PKN1 (unknown origin) by TR-FRET assay	B	NC(=O)c1cc(Br)cc2[nH]c(-c3ccncc3)nc12		CHEMBL4647033	=	Ki	nM	2190.0	CHEMBL3384	Homo sapiens	Ki	uM	2.19
	20706261	CHEMBL4628246	Inhibition of His/GST-tagged PKN1 (unknown origin) using biotinylated peptide as substrate measured after 1 hr in presence of [gamma-33P]-ATP by fluorescence microplate reader assay	B	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	100000.0	CHEMBL3384	Homo sapiens	Ki	uM	100.0
	22392147	CHEMBL4667242	Inhibition of recombinant human GST-tagged full length PRK1 expressed in baculovirus expression system using Ser/Thr 07 as substrate at 10 uM incubated for 60 mins by Z'-lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	1.0	CHEMBL3384	Homo sapiens	INH	%	1.0
	22423299	CHEMBL4674225	Inhibition of human PKN1 using KKLNRTLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	112.7	CHEMBL3384	Homo sapiens	Activity	%	112.7
	22423300	CHEMBL4674225	Inhibition of human PKN1 using KKLNRTLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	78.82	CHEMBL3384	Homo sapiens	Activity	%	78.82
	22843594	CHEMBL4720580	Inhibition of human PKN1 using KKLNRTLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	4.21	CHEMBL3384	Homo sapiens	IC50	10^-9M	4.21
	22843939	CHEMBL4720925	Inhibition of human PKN1 assessed as residual activity using KKLNRTLSVA as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	86.72	CHEMBL3384	Homo sapiens	Activity	%	86.72
	22844842	CHEMBL4721517	Inhibition of wild-type human partial length PKN1 (E598 to C948 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	94.84	CHEMBL3384	Homo sapiens	Activity	%	94.84
	22845459	CHEMBL4721740	Binding affinity to Nluc-tagged PKN1 (unknown origin) expressed in HeLa cells assessed as change in melting temperature incubated for 30 to 60 mins by NaLTSA assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Delta Tm	degrees C	1.96	CHEMBL3384	Homo sapiens	deltaTm	degrees C	1.96
	23120956	CHEMBL4804477	Inhibition of PKN1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	19000.0	CHEMBL3384	Homo sapiens	IC50	uM	19.0
	23120957	CHEMBL4804477	Inhibition of PKN1 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	40500.0	CHEMBL3384	Homo sapiens	IC50	uM	40.5
	23120958	CHEMBL4804477	Inhibition of PKN1 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	1800.0	CHEMBL3384	Homo sapiens	IC50	uM	1.8
	23120959	CHEMBL4804477	Inhibition of PKN1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-72100.0	CHEMBL3384	Homo sapiens	IC50	uM	-72.1
	23120960	CHEMBL4804477	Inhibition of PKN1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	35900.0	CHEMBL3384	Homo sapiens	IC50	uM	35.9
	23120961	CHEMBL4804477	Inhibition of PKN1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	56900.0	CHEMBL3384	Homo sapiens	IC50	uM	56.9
	23121996	CHEMBL4804659	Inhibition of PKN1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL3384	Homo sapiens	INH	%	0.0
	23121997	CHEMBL4804659	Inhibition of PKN1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	35.0	CHEMBL3384	Homo sapiens	INH	%	35.0
	23121998	CHEMBL4804659	Inhibition of PKN1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL3384	Homo sapiens	INH	%	0.0
	23121999	CHEMBL4804659	Inhibition of PKN1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL3384	Homo sapiens	INH	%	0.0
	23122000	CHEMBL4804659	Inhibition of PKN1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	50.0	CHEMBL3384	Homo sapiens	INH	%	50.0
	23122762	CHEMBL4805113	Inhibition of human PKN1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	100.0	CHEMBL3384	Homo sapiens	Activity	%	100.0
	23123457	CHEMBL4805701	Inhibition of human PKN1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	99.0	CHEMBL3384	Homo sapiens	Activity	%	99.0
	23123912	CHEMBL4806156	Inhibition of DNA-tagged human PKN1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL3384	Homo sapiens	Activity	%	100.0
	23125004	CHEMBL4806718	Inhibition of human PKN1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	96.0	CHEMBL3384	Homo sapiens	Activity	%	96.0
	23125005	CHEMBL4806718	Inhibition of human PKN1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL3384	Homo sapiens	Activity	%	100.0
	23128497	CHEMBL4807974	Inhibition of PRK1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL3384	Homo sapiens	Activity	%	75.0
	23128498	CHEMBL4807974	Inhibition of PRK1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL3384	Homo sapiens	Activity	%	75.0
	23128499	CHEMBL4807974	Inhibition of PRK1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL3384	Homo sapiens	Activity	%	75.0
	23158858	CHEMBL4812110	Inhibition of full length N-terminal GST-tagged PAK1 (1 to 545 residues) (unknown origin) expressed in Sf21 at 10 uM preincubated for 10 mins followed by peptide substrate addition relative to control	B	CC(C)(C)OC(=O)c1ccc(NC(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)cc1		CHEMBL4860361	=	Inhibition	%	9.32	CHEMBL3384	Homo sapiens	INH	%	9.32
Active	23232386	CHEMBL4827253	Inhibition of PAK1 transcriptional activity in human KMS-11 cells assessed as reduction in H3K36 methylation at 10 uM measured after 72 hrs by chip q-PCR analysis	B	Cl.Nc1cccc2c(S(=O)(=O)NCc3ccccc3)cccc12		CHEMBL4854710		Inhibition	%		CHEMBL3384	Homo sapiens	INH		
Not Active	23317598	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23318066	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23318732	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23319216	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23319853	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23320328	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	85.0	CHEMBL3384	Homo sapiens	% Control	%	85.0
Not Active	23321006	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	88.0	CHEMBL3384	Homo sapiens	% Control	%	88.0
Not Active	23321474	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23322104	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	87.0	CHEMBL3384	Homo sapiens	% Control	%	87.0
Not Active	23322572	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23323261	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	96.0	CHEMBL3384	Homo sapiens	% Control	%	96.0
Not Active	23323729	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23324583	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	91.4	CHEMBL3384	Homo sapiens	% Control	%	91.4
Not Active	23325218	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	88.0	CHEMBL3384	Homo sapiens	% Control	%	88.0
Not Active	23325686	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	97.0	CHEMBL3384	Homo sapiens	% Control	%	97.0
Not Active	23326333	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23326801	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23327501	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23327969	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23328556	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	98.0	CHEMBL3384	Homo sapiens	% Control	%	98.0
Not Active	23329024	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23329501	CHEMBL4881208	PRK1(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	114.0	CHEMBL3384	Homo sapiens	% residual kinase activity	%	114.0
Not Active	23329970	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23330438	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23331194	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23331662	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23332249	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	96.7	CHEMBL3384	Homo sapiens	% Control	%	96.7
Not Active	23332715	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23333433	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	71.1	CHEMBL3384	Homo sapiens	% Control	%	71.1
Not Active	23334072	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23334540	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23335519	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	72.0	CHEMBL3384	Homo sapiens	% Control	%	72.0
Not Active	23335987	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23336614	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23337082	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23337729	CHEMBL4882100	PKN1 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	98.5	CHEMBL3384	Homo sapiens	% Ctrl	%	98.5
Not Active	23338163	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	99.0	CHEMBL3384	Homo sapiens	% Control	%	99.0
Not Active	23338631	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	84.0	CHEMBL3384	Homo sapiens	% Control	%	84.0
Not Active	23339243	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23339711	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	85.0	CHEMBL3384	Homo sapiens	% Control	%	85.0
Not Active	23340348	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23340816	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23341473	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	87.0	CHEMBL3384	Homo sapiens	% Control	%	87.0
Not Active	23341941	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23342557	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	83.0	CHEMBL3384	Homo sapiens	% Control	%	83.0
Not Active	23343025	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	84.0	CHEMBL3384	Homo sapiens	% Control	%	84.0
Not Active	23343655	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23344123	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	90.0	CHEMBL3384	Homo sapiens	% Control	%	90.0
Not Active	23344761	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	76.0	CHEMBL3384	Homo sapiens	% Control	%	76.0
Not Active	23345334	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23345802	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23346379	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	96.9	CHEMBL3384	Homo sapiens	% Control	%	96.9
Not Active	23346847	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23347449	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	89.3	CHEMBL3384	Homo sapiens	% Control	%	89.3
Not Active	23347939	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	93.1	CHEMBL3384	Homo sapiens	% Control	%	93.1
Not Active	23348518	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	92.0	CHEMBL3384	Homo sapiens	% Control	%	92.0
Not Active	23348986	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23349573	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23350191	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	96.0	CHEMBL3384	Homo sapiens	% Control	%	96.0
Not Active	23350659	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23351264	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	83.0	CHEMBL3384	Homo sapiens	% Control	%	83.0
Not Active	23351732	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	90.0	CHEMBL3384	Homo sapiens	% Control	%	90.0
Not Active	23352182	CHEMBL4882871	PKN1 (PRK1) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	1.464	CHEMBL3384	Homo sapiens	% Inhibition	%	1.4638
Not Active	23352756	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	91.0	CHEMBL3384	Homo sapiens	% Control	%	91.0
Not Active	23353224	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23354106	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23354574	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23355306	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23355774	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23356410	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23356878	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23357487	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23358134	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23358602	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23359188	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23359786	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	65.0	CHEMBL3384	Homo sapiens	% Control	%	65.0
Not Active	23360254	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	83.0	CHEMBL3384	Homo sapiens	% Control	%	83.0
Not Active	23360839	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23361307	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	95.0	CHEMBL3384	Homo sapiens	% Control	%	95.0
Not Active	23361880	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23362416	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23362884	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	98.0	CHEMBL3384	Homo sapiens	% Control	%	98.0
Not Active	23364526	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	83.0	CHEMBL3384	Homo sapiens	% Control	%	83.0
Not Active	23364994	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23365733	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	91.0	CHEMBL3384	Homo sapiens	% Control	%	91.0
Not Active	23366276	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23366866	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	96.0	CHEMBL3384	Homo sapiens	% Control	%	96.0
Not Active	23367334	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23367716	CHEMBL4884069	PRK1 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	92.0	CHEMBL3384	Homo sapiens	% Residual activity with Skepinone-L	%	92.0
Not Active	23368212	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	95.0	CHEMBL3384	Homo sapiens	% Control	%	95.0
Not Active	23368680	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23369279	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23369747	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23370216	CHEMBL4884458	PRK1(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	74.0	CHEMBL3384	Homo sapiens	% residual kinase activity	%	74.0
Not Active	23370715	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23371183	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	78.0	CHEMBL3384	Homo sapiens	% Control	%	78.0
Not Active	23371992	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	72.0	CHEMBL3384	Homo sapiens	% Control	%	72.0
Not Active	23372460	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	98.0	CHEMBL3384	Homo sapiens	% Control	%	98.0
	23372848	CHEMBL4884813	PKN1 [PRK1(PKN1LGY1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL3384	Homo sapiens	pIC50		6.0
	23373257	CHEMBL4885104	PKN1 [PRK1(PKN1LGY1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL3384	Homo sapiens	pIC50		6.0
	23373614	CHEMBL4885391	PKN1 [PRK1(PKN1LGY1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL3384	Homo sapiens	pIC50		6.0
Not Active	23375082	CHEMBL4886070	PRK1 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	0.5	CHEMBL3384	Homo sapiens	% Inhibition	%	0.5
Not Active	23375887	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23376355	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23376932	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	77.0	CHEMBL3384	Homo sapiens	% Control	%	77.0
Not Active	23377400	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	60.0	CHEMBL3384	Homo sapiens	% Control	%	60.0
Not Active	23378260	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	85.0	CHEMBL3384	Homo sapiens	% Control	%	85.0
Not Active	23378728	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	98.0	CHEMBL3384	Homo sapiens	% Control	%	98.0
Not Active	23379895	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23380363	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	91.0	CHEMBL3384	Homo sapiens	% Control	%	91.0
Not Active	23381057	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23381705	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23382173	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23382797	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Slightly Active	23383265	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	43.0	CHEMBL3384	Homo sapiens	% Control	%	43.0
Not Active	23383939	CHEMBL4887549	PKN1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	87.0	CHEMBL3384	Homo sapiens	% Ctrl	%	87.0
Not Active	23384437	CHEMBL4888032	PRK1(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	5.64	CHEMBL3384	Homo sapiens	% inhibition	%	5.64
Not Active	23384685	CHEMBL4888211	PKN1 (PRK1) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	-4.0	CHEMBL3384	Homo sapiens	% Inhibition	%	-4.0
Not Active	23385180	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL3384	Homo sapiens	% Control	%	100.0
Not Active	23385647	CHEMBL4879904	KinomeScan assay: inhibition of PKN1	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	99.0	CHEMBL3384	Homo sapiens	% Control	%	99.0
